Trial

NCT03716570

A Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BIIB054 in Japanese Participants With Parkinson's Disease
Phase ITERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
Biogen
Collaborators
Condition
Parkinson's Disease
Intervention
BIIB054
Why stopped
Affiliated study NCT03318523 did not meet its primary outcome measure of change from baseline measured by Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS) and did not demonstrate efficacy on secondary outcome measures
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-05-25